Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
4
×
boulder/denver blog main
boulder/denver top stories
cancer
4
×
deals
detroit blog main
detroit top stories
generic drugs
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
drug prices
eli lilly
fda
takeda pharmaceutical
teva pharmaceutical
bristol-myers squibb
cancer immunotherapy
cell therapy
What
bio
roundup
4
×
drugs
new
pharmaceutical
ahead
appetite
approval
asco
bails
biogen’s
biopharmaceutical
black
brand
branded
bread
bridgebio
butter
buyout
cancer
capital
car
cash
choices
commissioner
companies
consumers
convo
costly
counterweight
develop
diabetes
diamond’s
drug
earlier
elevatebio
eli
emerges
failures
fda
Language
unset
Current search:
roundup
×
" generic drugs "
×
" boston top stories "
×
cancer
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More